Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
  • European Conferences on Biomedical Optics 2021 (ECBO)
  • OSA Technical Digest (Optica Publishing Group, 2021),
  • paper ETu2A.37

Optical Coherence Tomography of Healthy and Malignant Tissues: Physically Reasonable Differentiation

Not Accessible

Your library or personal account may give you access

Abstract

Optical coherence tomography of the ex vivo human and rat brain tissue samples is performed. The analysis of attenuation coefficient, coefficient based on effective refractive index, and their standard deviations was obtained from OCT measurements.

© 2021 The Author(s)

PDF Article
More Like This
Study of malignant brain gliomas using optical coherence tomography and terahertz pulsed spectroscopy aimed on advanced intraoperative neurodiagnosis

Irina N. Dolganova, Polina V. Aleksandrova, Nikita V. Chernomyrdin, Sheykh-Islyam T. Beshplav, Aleksandra V. Kosyrkova, Pavel V. Nikitin, Arsenii A. Gavdush, Igor V. Reshetov, Valery V. Tuchin, and Kirill I. Zaytsev
11073_26 European Conference on Biomedical Optics (ECBO) 2019

Comparison of two optical coherence tomography systems to identify human brain tumor

P. Strenge, B. Lange, C. Grill, W. Draxinger, V. Danicke, D. Theisen-Kunde, H. Handels, M. M. Bonsanto, C. Hagel, R. Huber, and R. Brinkmann
EW1C.7 European Conference on Biomedical Optics (ECBO) 2021

Optical coherence tomography of human brain glioma as a promising tool for intraoperative diagnostics in neurosurgery

Polina V. Aleksandrova, Irina N. Dolganova, Nikita V. Chernomyrdin, Guzel R. Musina, Sheykh-Islyam T. Beshplav, Aleksandra V. Kosyrkova, Igor V. Reshetov, Valery V. Tuchin, and Kirill I. Zaytsev
11078_80 European Conference on Biomedical Optics (ECBO) 2019

Poster Presentation

Media 1: PDF (17639 KB)     
Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.